Forest Labs: Judge determines Lexapro patent valid (Market Watch)

Forest Labs: Judge determines Lexapro patent valid (Market Watch)
SAN FRANCISCO (MarketWatch) – A federal judge has found that Forest Laboratories Inc.’s patent covering the active ingredient in its depression treatment Lexapro is valid, company officials said Thursday evening.